These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
3. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. Hanson SR; Pareti FI; Ruggeri ZM; Marzec UM; Kunicki TJ; Montgomery RR; Zimmerman TS; Harker LA J Clin Invest; 1988 Jan; 81(1):149-58. PubMed ID: 2961790 [TBL] [Abstract][Full Text] [Related]
4. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595 [TBL] [Abstract][Full Text] [Related]
5. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. Harker LA; Hanson SR J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835 [TBL] [Abstract][Full Text] [Related]
6. The role of the platelet in the pathogenesis of atherothrombosis. Steinhubl SR; Moliterno DJ Am J Cardiovasc Drugs; 2005; 5(6):399-408. PubMed ID: 16259528 [TBL] [Abstract][Full Text] [Related]
7. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733 [TBL] [Abstract][Full Text] [Related]
8. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. Krupski WC; Bass A; Kelly AB; Ruggeri ZM; Harker LA; Hanson SR J Vasc Surg; 1993 Feb; 17(2):294-303; discussion 303-4. PubMed ID: 8433425 [TBL] [Abstract][Full Text] [Related]
9. Novel antithrombotic drugs in development. Verstraete M; Zoldhelyi P Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602 [TBL] [Abstract][Full Text] [Related]
10. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Michelson AD; Barnard MR; Hechtman HB; MacGregor H; Connolly RJ; Loscalzo J; Valeri CR Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11877-82. PubMed ID: 8876231 [TBL] [Abstract][Full Text] [Related]
11. The occupancy of glycoprotein IIb-IIIa complex modulates thrombin activation of human platelets. Sinigaglia F; Torti M; Ramaschi G; Balduini C Biochim Biophys Acta; 1989 Sep; 984(2):225-30. PubMed ID: 2548625 [TBL] [Abstract][Full Text] [Related]
12. Thrombin formation in vitro in response to shear-induced activation of platelets. Fallon AM; Marzec UM; Hanson SR; Yoganathan AP Thromb Res; 2007; 121(3):397-406. PubMed ID: 17532367 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis. Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806 [TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro. Hamilton SF; Miller MW; Thompson CA; Dale GL J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857. Rübsamen K; Hornberger W; Kirchengast M Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122 [TBL] [Abstract][Full Text] [Related]
16. Induction of transient neurological dysfunction in baboons by platelet microemboli. Kessler C; Kelly AB; Suggs WD; Weissman JD; Epstein CM; Hanson SR; Harker LA Stroke; 1992 May; 23(5):697-702. PubMed ID: 1533737 [TBL] [Abstract][Full Text] [Related]
17. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. Coller BS; Peerschke EI; Scudder LE; Sullivan CA J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050 [TBL] [Abstract][Full Text] [Related]
18. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Cook JJ; Sitko GR; Bednar B; Condra C; Mellott MJ; Feng DM; Nutt RF; Shafer JA; Gould RJ; Connolly TM Circulation; 1995 Jun; 91(12):2961-71. PubMed ID: 7796507 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048 [TBL] [Abstract][Full Text] [Related]